Skip to main content

Table 2 Concentration of flurbiprofen in the abluminal compartment measured by HPLC

From: Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model

μM luminally administered μM abluminally measured by HPLC % of administered concentration
300 μM flurbiprofen 41.85 13.95
300 μM PLA-flurbiprofen nanoparticles 31.56 10.52
450 μM PLA-flurbiprofen nanoparticles 46.82 10.40
600 μM PLA-flurbiprofen nanoparticles 63.95 10.66
750 μM PLA-flurbiprofen nanoparticles 83.70 11.16
\